Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-03-18 | Andrew C. von Eschenbach, M.D. Age 77 Independent 2018 Meeting Attendance: Board 1/1 Director Compensation Table: Andrew C. von Eschenbach, M.D. Fees Earned or Paid in Cash: 20,932 Stock Awards: 128,025 All Other Compensation: 0 Total: 148,957 |
| 2020-03-16 | Andrew C. von Eschenbach, M.D. Age 78 Independent 2019 Meeting Attendance: Board 6/6, Science and Technology Committee 4/4. Director Compensation Table: Fees Earned or Paid in Cash $120,000, Stock Awards $250,000, Total $370,000. |
| 2021-03-18 | Andrew C. von Eschenbach, M.D. Texas, USA Age 79 Independent Stock Ownership: 2,100 Common Shares $66,675 27,502 RSUs (comprised of 16,465 vested RSUs $522,764, and 11,037 unvested RSUs $350,425) Total Equity Value at Risk: $589,439, representing 118% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 589% of the annual Board retainer. 2020 Meeting Attendance: Board 9/9 Science and Technology Committee 6/6 |
| Filing Date | Source Excerpt |
|---|---|
| 2013-10-07 | Dr. von Eschenbach is an internationally renowned cancer specialist and author of more than 300 scientific articles and studies, and served for over three decades as a physician, surgeon, oncologist, and executive in the healthcare industry. |
Data sourced from SEC filings. Last updated: 2026-02-03